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ABSTRACT
JESSICA JEAN HOLT: The Role of Inducible Nitric Oxide Synthase in Ischemic
Preconditioning ofa Muscle Flap in a Rat Model
(Under the direction of Dr. Kenneth Sufka)
Fifty male Sprague-Dawley rats were used in this study. The gracilis muscle flap with
femoral vascular pedicle was dissected and used as a flap model. The ischemic
preconditioning period consisted ofthree cycles ofclamping the pedicle for 10 minutes
followed by 10 minutes of reperfusion resulting in a total of 1 hour. In part I, the
experimental group underwent the ischemic preconditioning for 1 hour. In the control
group, the flaps were dissected without the clamping ofthe pedicle. Both groups were
then subjected to 4 hours of global ischemia by continuous pedicle clamping, after which
the flaps were sutured to their beds. Three days after the operation, the survival ofthe
flaps was determined by gross and histological examinations. In part II, the experimental
group underwent ischemic preconditioning, while the control group did not. The flaps
from each group were harvested for iNOS gene expression using RT-PCR after 1 hour of
perfusion and again after 4 hours ofischemia. The results indicated a significantly higher
survival rate in the experimental group, with preconditioning than the non-preconditioned
control group. iNOS gene expression was also significantly higher in the experimental
groups than the control group at 1 hour after ischemic preconditioning. However, after 4
hours of global ischemia, iNOS expression in the control group was statistically higher
than the experimental group. In conclusion, ischemic preconditioning can enhance flap
tolerance to ischemic injury and improve flap survival rate. This study also provides
evidence that the regulation of NOS may play an important role in the ischemic
preconditioning phenomenon and thus the precise function of NOS in ischemia
preconditioning warrants further investigation.
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Introduction
Microsurgical flaps have been widely used in clinical reconstructive surgery to
successfully provide defect coverage while simultaneously restoring the form and
function of the site of the defect without causing deformity ofthe donor site^ Though
these procedures have achieved great clinical success, the incidence offlap failure still
remains between 5 and 10 percent.^’^ Prolonged ischemia and oxygen-derived free
radicals induce peroxidation and cause ischemia-induced reperfusion injury during intraor post-operative complications. They are thus believed to be the major cause offlap
failure. 4.5 Ischemia is a low oxygen state usually due to obstruction ofthe arterial blood
supply or inadequate blood flow leading to hypoxia and ultimately necrosis, or cell death,
in the tissue. Ischemia occurs in microsurgical flaps because the pedicle, the source of
artery and vein that represent the flap circulation to maintain tissue viability, must be
ligated in order to transfer the flap from the donor site to the recipient site. During the
time between the ligation of the pedicle and microsurgical anastomoses, or joining, ofthe
pedicle to the recipient vessel, the flap experiences a lack of oxygen, or primary
ischemia. After the flap has been transferred and the anastomosis ofthe pedicle
to the recipient vessel is complete, thrombosis or clotting can occur at the site of
1

anastomosis of the newly established vessel and cause secondary ischemia in the flap.
Increasing flap tolerance to ischemia-reperfusion injury may increase the possibility of
salvaging the flap with complications.
While great efforts have been made to pharmacologically reduce ischemia reperfusion
injury, research in the cardiology field found that brief periods of coronary artery
occlusion, followed by episodes ofreperfusion, could increase the resistance to further

1

ischemic damage in myocardial muscle.®’^ This ischemic preconditioning technique has
been applied to experimental and clinical microsurgical flap transfers. In animal muscle
flap models, the survival of the muscle flap was improved ifthe main ischemic insult was
preceded by a preconditioning session.^’^ Preconditioning has also been found to be
10,11

Geffective in decreasing muscle functional impair after prolonged ischemia.

The mechanism of the effect of ischemic preconditioning phenomenon on flap survival is
still under intense investigation. One theory involves the ability ofischemic
preconditioning to increase functional capillary perfusion and reduce leukocyte-mediated
12-14

inflammation in the tissue with reperfusion injury.

Another theory is based on the

molecular mechanisms involved in ischemia preconditioning injury such as the
phosphorylation of the adenosine triphosphate-dependent potassium channel(Katp
channel) which increases the K+ efflux and thus exerts their cardioprotective effect. Pre
conditioning is an adaptation triggered by many different chemical signals during the
original ischemic stress. The chemical messengers can include Adenosine, bradykinin,
catecholamines, and nitric oxide, all of which have been reported to exert their effects on
13,15

these Katp chaimels.

Because so many chemicals trigger preconditioning, the

removal of one, such as Nitric Oxide, does not block the development of protection in the
presence of other stimuli. However, exogenous supplementation of Nitric Oxide, such as
15

SNAP or nitroglycerin, can produce a pre-conditioning response against ischemia.
According to the nitric oxide hypothesis of late preconditioning,ischemic
preconditioning occurs in two phases, termed the early and late phases of
preconditioning. The early phase of preconditioning occurs immediately after the initial
ischemic insult and lasts 2-3 hours, while the late phase of preconditioning begins 12-24

2

hours later and lasts three to four days.*^ Both phases ofpreconditioning are useful in a
clinical setting. The early phase of preconditioning would provide protection against
primary ischemia, while the late phase would be associated with the protection against
secondary ischemia. The two-phase process of preconditioning is due to the mechanism
by which nitric oxide provides ischemic protection. Nitric Oxide plays a prominent role
in both initiating an adaptive response when a preconditioning stimulus is applied and
mediating the protection hours later.*^’’^ According to this hypothesis, a brief episode of
ischemic stress causes increased production of Nitric Oxide(NO)and reactive O2probably by eNOS. NO and the reactive oxygen species activate protein Kinase C
epsilon(PKCs)via an unknown mechanism. PKCe then triggers a complex signaling
cascade involving Src and Lck tyrosine kinases, leading to the phosphorylation ofIkBa
and mobilization of the transcription factor NF-kB. Other transcription factors are
thought to be involved including the JAK/STAT signaling pathway. STAT has been
determined to be required for iNOS regulation. Binding of NF-kB and STAT to the
iNOS promoter results in the activation ofthe promoter and the transcription ofthe iNOS
gene, thus increasing synthesis ofthe iNOS protein. An increased production ofthe
15,16

iNOS protein results in enhanced NO biosynthesis and a preconditioned phenotype.

Other studies have agreed that NO is responsible for the protective preconditioned state,
but have also concluded that the accumulation of NO is harmful. They suggest that NO
preconditioning(or iNOS inhibitors) blockades the overproduction and thus
accumulation of NO that is harmful to the tissue. While these important studies focused
on myocardium, little research has been reported to apply these studies to skeletal muscle
pre-conditioning. In this study we examined the molecular marker ofNO to determine its

3

role in correlation with ischemic preconditioning on improving muscle flap survival in a
rat model.

4

I. Materials and Methods
Fifty male Sprague-Dawley rats weighing between 380-420 grams and cared for under
the National Research Council’s guidelines for the care and use oflaboratory animals
were used in this study. The rats were anesthetized using pentobarbital administered by
intraperitoneal injection (50 mg/kg). Following induction ofgeneral anesthesia, the
lower abdomen and groin were shaved, and the animals were placed in a supine position.

Flap model and preconditioning protocol
The right groin vessels and gracilis muscles were exposed by using a transverse groin
incision. The gracilis muscle flap was elevated with femoral vascular pedicle. The
preconditioning protocol was designed based previous protocol investigating
19

preconditioning in the rat flap models,

The treatment muscle flap underwent ischemic

preconditioning by 10 minutes of pedicle clamping using Acland V3 clamps followed by
10 minutes of reperflision. This ischemia/reperfusion sequence was repeated three times
for a total preconditioning period of 1 hour. The experiment was divided into two parts.

Part I. Flap survival
T’wenty rats were divided into two groups. In the experimental group (n=10), the muscle
flap underwent the ischemic preconditioning procedures for 1 hour. Then the muscle flap
was subjected to 4 hours of global ischemia induced by pedicle clamping. In the control

5

group, the muscle Hap was simply perfused without clamping for 1 hour after dissection,
and then subjected to 4 hours of ischemia. After ischemia time, the clamps were released,
and the flaps from both groups were

fixed to their original location, after which the

overlying skin was sutured with running 4-0 Nylon sutures.
The animals were allowed to recover in their individual cages a period of72 hours. After
this time, the animals were once again anesthetized as described above. Survival ofthe
flaps was determined by gross examination oftheir color, texture, and vascular supply.
The flaps were then removed and placed in 10% formalin for histology.

Part II. Inducible nitric oxide synthase(iNOS)gene expression
Thirty rats were used in this part of the study. The animals were divided into two groups
as above. In the experimental group (n=12), the muscle flaps underwent preconditioning
procedures followed by an ischemia period. Six flaps were harvested at the end of 1 hour
of preconditioning and others were harvested at the end of4 hours of global ischemia for
examination. In the control (n=12), six flaps were harvested at the end of 1 hour
perfusion and the remaining six were harvested at the end of4 hours global ischemia. The
samples from normal gracilis muscle(n=6) were examined for the baseline of gene
expressions.

RT-PCR
iNOS mRNA from the muscle samples of each group were examined. The biopsied
tissues were homogenized, and the total RNA was isolated from the skin using Trizol
reagent(GIBCO BRL, Gaithersburg, MD). The extracted RNA was then reverse
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transcribed into cDNA. The reaction was performed in a final volume of25 pL,
consisting of 2.5 pL lOx PCR buffer, 1.5 pL of25 mM MgCl2,2pl mixture of 1 mM
dNTP,0.125 pi of Taq DNA polymerase (5U/pl), 1.5 pL ofeach primer 50 pM,and 1
pL of cDNA. The typical PCR reaction conditions were 2 minutes at 94°C, and then 35
cycles at 94"C for 50 seconds, 60°C for 50 seconds, and 72°C for 50 seconds. After the
cycles were complete, the reactions continued with conditions at 72°C for 10 minutes and
then remaining at 4°C . The primer was obtained commercially(The Midland Certified
Reagent Company, Midland, TX).PCR products were subjected to 10% polyacrylamide
gel electrophoresis. The gel with the separated DNA bands were photographed and
scanned. To ensure that equal amounts ofreverse-transcribed cDNA were applied to the
PCR reaction, the primer pairs for p-actin, a constitutively expressed gene, were also
included in the PCR reaction. Quantitative gene expression was expressed as fraction of
iNOS to p-actin.
After flap survival examination and tissue biopsies, the animals were sacrificed by an
overdose of pentobarbital. The data on flap survival from different groups were compared
using a chi-square test. The data on gene expression from different groups were
compared using one-way analysis of variance(ANOVA)for multiple testing. Statistical
significance was assumed at p<0.05.

II. Results

Flap survival
The surviving flaps were pink, pliable and appeared well perfused. The consistency of
the muscle w'as normal and it displayed healthy circulation as evidenced by the patent
vascular pedicle and by cutting into it with a scalpel. In contrast, non-viable flaps were
distinguished based on the lack of circulation in the flap and the extensive thrombosis in
the vascular pedicle. These flaps were pale in appearance, as well as being very thin and
firm relative to the surviving ones.
The results of flap survdval are shown in Figure 1. After 4 hours ischemia, 9 of the 10
flaps in the experimental group that had undergone ischemic preconditioning survived,
while only 5 of the 10 flaps survived in the control group without preconditioning. There
was a significant difference between the survival rates of these two groups (p<0.05).

Figure 1 - Comparison of flap survival
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Histology
Histological analysis confirmed that the flaps that were determined to have survived
based on gross examination were in fact alive and viable. Among the surviving flaps, the
muscle fibers were more organized with less evidence ofdamaged myocytes and
architectural disarray. The capillaries appeared normal and showed no indication of
endothelial damage. The muscle of non-viable flaps had loss of striations, fragmentations
and nuclear dropout indicating that extensive myonecrosis had occurred.

Gene expression
Gene expression was expressed as a fraction of growth factors to p-actin(Mean ±
standard deviation). The expression ofiNOS was detected in the flaps. The iNOS
expression from normal gracilis muscle was 0.27 ± 0.09. In the experimental group, the
mean iNOS expression from the flaps was 0.73 ±0.18 after 1 hour ischemic
preconditioning, which was significantly higher than iNOS from the control flaps with 1
hour perfusion without preconditioning (0.26 ± 0.11) and the normal muscle samples
(p<0.01). However, after 4 hours global ischemia, the fraction ofiNOS expression in the
flaps with preconditioning was significantly decreased to 0.26 ± 0.07 while iNOS in the
control was increased to 0.83 ±0.16. The changes ofiNOS expressions ofthese two
groups are shown in Figure 2 and 3.
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Figure 2 - iNOS gene expression in flaps with
ischemic preconditioning
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Figure 3 - iNOS gene expression in flaps without
ischemic preconditioning
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Ill- Discussion
Nitric Oxide has been a very popular and controversial issue in preconditioning research.
It has been found to initiate the protective preconditioned state, but has also been
determined to be harmful in accumulation.*^ Preconditioning seems to not only be
responsible for the initiation of the production of NO,but also the regulation ofthe
production and thus prevention of the overproduction and accumulation ofharmful levels
of NO although the precise mechanism is still under investigation.*^ The detrimental role
of NO in accumulation seems to be due to the formation ofhighly reactive oxidant
20

species.

It has been proposed that preconditioning induces upregulation ofiNOS gene expression
and thus NO sythesis. The introduction ofiNOS inhibitors such as N-nitro-L-arginine
(LNA)or aminoguanidine has provided further support for this theory. When inhibitors
such as these were introduced after preconditioning, but before the prolonged ischemic
period, the protective effect of preconditioning was completely invalidated (Takano and
*^’^*). However, the research of Csonka et al.*^ rebuked these findings. It indicated that
the effects of preconditioning were invalidated if

the iNOS inhibitor, LNA was given

prior to preconditioning, but that the protective preconditioned state was unaltered if
LNA was given after preconditioning but before the prolonged ischemic period 17
Therefore it was determined that both preconditioning or an appropriate concentration of
iNOS inhibitor decreases injury due to ischemia as is indicated by an
ischemic function.

17

11

enhanced post-

The role of nitric oxide in preconditioning as stated by the nitric oxide hypothesis oflate
16,17

preconditioning was further supported by this study.

The amount ofNO present after

1 hour of preconditioning was significantly higher than the amount ofNO present in the
control non-preconditioned muscle flaps with 1 hour of perfusion. This supports the
hypothesis that the protective effect of ischemia preconditioning is triggered by an
increase in NO.16.17 The decreased levels of NO accumulation after 4 hours ofglobal
ischemia in preconditioned flaps versus the NO levels in non-preconditioned flaps again
supports previous research when the survival ofthese flaps is taken into account.^^’^^ The
preconditioned flaps that had lower levels ofiNOS after four hours of global ischemia
were found to be alive and viable, while the non-preconditioned flaps that had
significantly higher levels of iNOS after the four hours of global ischemia were nonviable
and had extensive myonecrosis. Thus one might conclude that ischemia preconditioning
induces an iNOS cascade that in turn preconditions the tissue against further ischemia by
preventing overproduction of NO during subsequent ischemic periods. This mechanism
seems to occur much in the same way that vaccines prevent the development ofillness by
exposing the body to small amotmts of harmful substance in order that the body might
develop its own defense. However,the precise mechanism by which the ischemia
preconditioning induced iNOS prevents the harmful accumulation of NO during
subsequent ischemic periods is yet to be determined and thus would warrant further
investigation.
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IV. Conclusion
Ischemia preconditioning is useful in preventing injury and loss offunction due to
ischemic periods in muscle flaps, and Nitric Oxide Synthase has been determined to have
a vital role in the mechanism by which preconditioning prevents this ischemic injury.
However, the specific pathway by which iNOS flmctions is not yet fully understood.
Perhaps through further investigation of preconditioning and the function ofiNOS in the
preconditioning event, injury due to ischemia can be prevented clinically through the use
of iNOS inducers and inhibitors and the careful monitoring ofiNOS levels within the flap
tissue.
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